Wordt geladen...
Glucagon‐like peptide‐1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway
Lipotoxicity cardiomyopathy is the result of excessive accumulation and oxidation of toxic lipids in the heart. It is a major threat to patients with diabetes. Glucagon‐like peptide‐1 (GLP‐1) has aroused considerable interest as a novel therapeutic target for diabetes mellitus because it stimulates...
Bewaard in:
| Gepubliceerd in: | Aging Cell |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6052396/ https://ncbi.nlm.nih.gov/pubmed/29659121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acel.12763 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|